Pelliciari, D. H. S., Reis, C. R. A., & Bordini, C. A. (2024). Should anti-CGRP monoclonal antibodies always be the drug of first choice for migraine prophylaxis in Brazil? – a pharmacoeconomic study. Headache Medicine, 15(Supplement), 98. Retrieved from https://headachemedicine.com.br/index.php/hm/article/view/1230